[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335580-105":59,"doc-detail-335580-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","magnesium-related-gene-itgal-a-key-immunotherapy-predictor-and-prognostic-biomarker-in-pan-cancer","Magnesium-related gene ITGAL - a key immunotherapy predictor and prognostic biomarker in pan-cancer","","Magnesium-related gene ITGAL is investigated as a driver of tumor immunity and a potential clinical biomarker. The study analyzes ITGAL expression across 27 cancers and validates findings using immunohistochemistry, linking high ITGAL to distinct survival outcomes in selected tumor types. Results associate ITGAL with immune regulation pathways and immune cell infiltration, including CD8+ T cells, and in HNSCC connect ITGAL to favorable prognosis and predicted immunotherapy sensitivity. Predicted drug implications for HNSCC are discussed.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/magnesium-related-gene-itgal-a-key-immunotherapy-predictor-and-prognostic-biomarker-in-pan-cancer/335580/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/magnesium-related-gene-itgal-a-key-immunotherapy-predictor-and-prognostic-biomarker-in-pan-cancer/335580.png","ImageObject",300,407,{"name":92,"@type":93},"Seraphina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What does the study evaluate regarding ITGAL in pan-cancer patients?","Question",{"text":113,"@type":114},"The study evaluates ITGAL expression across multiple cancers, its prognostic significance, correlations with clinical features, and links to immune regulation pathways and immune cell infiltration.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How is ITGAL validated in this research?",{"text":118,"@type":114},"ITGAL expression patterns are comprehensively analyzed across cancers and validated using immunohistochemistry (IHC) in the laboratory.",{"name":120,"@type":111,"acceptedAnswer":121},"What is the reported relationship between ITGAL and immunotherapy in HNSCC?",{"text":122,"@type":114},"In HNSCC, ITGAL is linked to favorable prognosis and sensitivity to immunotherapy, and the study predicts potential drugs targeting this context.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},335580,1790674726,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},962075114101,"https://ap-avatar.wpscdn.com/avatar/e000253a75eb197efd?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780044092746381165","TYPE Original Research PUBLISHED 13 November 2024 DOI 10.3389/fphar.2024.1464830  \nOPEN ACCESS  \nEDITED BY  \nFujun Han,  \nThe First Hospital of Jilin University, China  \nREVIEWED BY  \nRuo Wang,  \nShanghai Jiao Tong University, China Mercy Rophina,  \nNew York University, United States  \n*CORRESPONDENCE  \nSufang Qiu,  \n [sufangqiu@fjmu.edu.cn](sufangqiu@fjmu.edu.cn)[ ](sufangqiu@fjmu.edu.cn)Yunbin Ye,  \n [yeyb@fjzlhospital.com](yeyb@fjzlhospital.com)  \n†These authors have contributed equally to this work and share ﬁrst authorship  \nRECEIVED 15 July 2024  \nACCEPTED 29 October 2024  \nPUBLISHED 13 November 2024  \nCITATION  \nLin F, Yang H, Huang Z, Li Y, Ding Q, Ye Y and Qiu S (2024) Magnesium-related gene ITGAL: a key immunotherapy predictor and prognostic biomarker in pan-cancer.  \nFront. Pharmacol. 15:1464830 .  \ndoi: 10.3389/fphar.2024.1464830  \nCOPYRIGHT  \n© 2024 Lin, Yang, Huang, Li, Ding, Ye and Qiu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nMagnesium-related gene ITGAL: a key immunotherapy predictor and prognostic biomarker in  \npan-cancer  \nFengjie Lin 1†, Hanxuan Yang 1†, Zongwei Huang 1, Ying Li 1, Qin Ding 1, Yunbin Ye 2,3* and Sufang Qiu 1*  \n1Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fujian, China, 2Laboratory of Immuno-Oncology, Fujian Cancer Hospital and Fujian Medical University Cancer, Hospital, Fuzhou, China, 3Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, China  \nBackground: Integrin subunit alpha L (ITGAL) is crucial for activating CD8+ T cells through magnesium-mediated immune synapse formation and speciﬁccytotoxicity. ITGAL might exert an important function in the growth and transformation of cancer.  \nMethods: Our study comprehensively analyzed ITGAL expression across various cancers, validated by Immunochemistry (IHC) in the laboratory. ITGAL showed prognostic signiﬁcance in pan-cancer patients, correlated with clinical features, and associated with speciﬁc signaling pathways. We also observed a relationship between ITGAL and immune cell inﬁltration. In HNSCC, ITGAL demonstrated prognostic value and potential implications for immunotherapy response and novel drug targets.  \nResults: ITGAL expression linked to tumor prognosis across 27 cancers. Elevated ITGAL correlated with good prognosis in CESC, LUAD, SARC, HNSCC, and SKCM. ITGAL involved in immune regulation pathways and showed positive correlation with immune cell inﬁltration. ITGAL associated with CD8+ T cell inﬁltration. And high ITGAL expression in CD8+ T cells and NK cells. In HNSCC, ITGAL linked to favorable prognosis and sensitivity to immunotherapy. Predicted potential drugs for HNSCC.  \nConclusion: ITGAL is remarkably associated with CD8+T cells and crucial in the tumor immune microenvironment of pan-cancer. Furthermore, our ﬁndings may provide a targeted anti-tumor strategy for ITGAL by inﬂuencing the tumor immune microenvironment.  \nKEYWORDS  \nITGAL, pan-cacner, immunothearpy, magnesium-related, HNSCC  \nIntroduction  \nIntegrin alpha L chain encoded by integrin subunit alpha L (ITGAL) is critically involved in intercellular adhesion between leukocytes by binding to intercellular adhesion molecules 1–3 (ICAMs 1–3) (Corbi et al., 1988; Hickman et al., 2022) . Moreover, previous studies have demonstrated that the LFA-1 (Lymphocyte Function-associated Antigen 1) encoded by ITGAL is crucial in the inﬂammatory response (Whitcup et al., 1999), which  \nFrontiers in Pharmacology 01 [frontiersin.org](frontiersin.org)  \nincludes cytotoxic T cell dependent killing, ant","cbCaihgWRPXLMEHo","https://ap.wps.com/l/cbCaihgWRPXLMEHo","pdf",6978023,"English","# Background\n## Integrin alpha L (ITGAL) and magnesium-mediated immune synapse formation\n# Methods\n## Pan-cancer ITGAL expression analysis\n## Immunohistochemistry (IHC) validation\n## Clinical correlations and pathway association\n# Results\n## ITGAL prognostic value across 27 cancers\n## Correlation with immune cell infiltration\n## Findings in HNSCC and implications for immunotherapy\n# Conclusion\n## ITGAL as a target within the tumor immune microenvironment","[{\"question\":\"What does the study evaluate regarding ITGAL in pan-cancer patients?\",\"answer\":\"The study evaluates ITGAL expression across multiple cancers, its prognostic significance, correlations with clinical features, and links to immune regulation pathways and immune cell infiltration.\"},{\"question\":\"How is ITGAL validated in this research?\",\"answer\":\"ITGAL expression patterns are comprehensively analyzed across cancers and validated using immunohistochemistry (IHC) in the laboratory.\"},{\"question\":\"What is the reported relationship between ITGAL and immunotherapy in HNSCC?\",\"answer\":\"In HNSCC, ITGAL is linked to favorable prognosis and sensitivity to immunotherapy, and the study predicts potential drugs targeting this context.\"}]","Magnesium-related gene ITGAL - a key immunotherapy predictor and prognostic biomarker in pan-cancer | PDF",1790011495,48]